https://www.finanzwire.com/article/sanofis-vaccine-shows-superior-tolerability-in-recent-study-TfYQdozAify 2026-04-18T10:05:00.000Z daily 0.8 Finanzwire en 2026-04-18T10:05:00.000Z Sanofi's Vaccine Shows Superior Tolerability in Recent Study Blog COVID-19,Sanofi,Nuvaxovid,Vaccine Study,Tolerability EPA:SAN https://www.finanzwire.com/article/sanofis-nuvaxovid-demonstrates-better-tolerability-compared-to-mnexspike-Ic3n9MfeJCj 2026-04-18T10:05:00.000Z daily 0.8 Finanzwire en 2026-04-18T10:05:00.000Z Sanofi's Nuvaxovid demonstrates better tolerability compared to mNEXSPIKE Blog Sanofi,Tolérance,Nuvaxovid,ESCMID,COVID-19 Vaccination EPA:SAN https://www.finanzwire.com/press-release/press-release-escmid-sanofis-nuvaxovid-covid-19-vaccine-showed-better-tolerability-than-mnexspike-in-head-to-head-study-maJJhtVEoL9 2026-04-18T10:00:00.000Z daily 0.8 Finanzwire en 2026-04-18T10:00:00.000Z Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study PressRelease COVID-19,Sanofi,Vaccine,Nuvaxovid,Tolerability EPA:SAN https://www.finanzwire.com/article/formation-metals-addresses-promotional-activity-concerns-ODwh4X1V54j 2026-04-18T02:05:00.000Z daily 0.8 Finanzwire en 2026-04-18T02:05:00.000Z Formation Metals Addresses Promotional Activity Concerns Blog Investor Relations,OTC Markets,Trading Volume,Formation Metals,Promotional Activity https://www.finanzwire.com/press-release/formation-metals-responds-to-otc-markets-request-on-recent-promotional-activity-yQeOiOlJEOk 2026-04-18T02:00:00.000Z daily 0.8 Finanzwire en 2026-04-18T02:00:00.000Z Formation Metals Responds to OTC Markets Request on Recent Promotional Activity PressRelease Investor Relations,OTC Markets,Formation Metals Inc.,Promotional Activity,Third-party Marketing Firms https://www.finanzwire.com/article/aiml-innovations-completes-share-issuance-M8TMop5eSJ8 2026-04-18T00:05:00.000Z daily 0.8 Finanzwire en 2026-04-18T00:05:00.000Z AI/ML Innovations Completes Share Issuance Blog Debt Settlement,Related Party Transaction,AI/ML Innovations,Share Issuance,Securities Regulation https://www.finanzwire.com/press-release/aiml-innovations-announces-completion-of-share-issuance-WRC0RFgbs25 2026-04-18T00:00:00.000Z daily 0.8 Finanzwire en 2026-04-18T00:00:00.000Z AI/ML Innovations Announces Completion of Share Issuance PressRelease AI/ML Innovations Inc.,Share Issuance,Insiders,Debt,Statutory Hold Period https://www.finanzwire.com/article/medicure-announces-leadership-change-bDbjIuVMnGc 2026-04-17T23:40:00.000Z daily 0.8 Finanzwire en 2026-04-17T23:40:00.000Z Medicure Announces Leadership Change Blog Pharmaceuticals,Strategic Priorities,Medicure Inc.,Leadership Change,United States Market NASDAQ:MCUJF https://www.finanzwire.com/press-release/medicure-announces-resignation-of-president-and-chief-operating-officer-Xd0LFVklBV2 2026-04-17T23:35:00.000Z daily 0.8 Finanzwire en 2026-04-17T23:35:00.000Z Medicure Announces Resignation of President and Chief Operating Officer PressRelease Pharmaceuticals,Resignation,Healthcare,Medicure Inc.,Leadership NASDAQ:MCUJF https://www.finanzwire.com/article/onco-innovations-enhances-leadership-with-key-appointments-610ITz10JB2 2026-04-17T23:05:00.000Z daily 0.8 Finanzwire en 2026-04-17T23:05:00.000Z Onco-Innovations Enhances Leadership with Key Appointments Blog Clinical Trials,Executive Appointments,Oncology Development,Research Strategy,Leadership In Biotechnology